Wall Street Pummels Altimmune Inc. (ALT) After Recent Earnings Report – News Heater
Home  »  Hot Stocks   »  Wall Street Pummels Altimmune Inc. (ALT) After Rec...

Wall Street Pummels Altimmune Inc. (ALT) After Recent Earnings Report

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Altimmune Inc. (NASDAQ:ALT) went down by -6.94% from its latest closing price compared to the recent 1-year high of $35.10. The company’s stock price has collected 8.98% of gains in the last five trading sessions. Press Release reported 13 hours ago that Thinking about buying stock in Clover Health Investments, New Oriental Education, Altimmune, BlackBerry, or Microvision?

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in Altimmune Inc. (NASDAQ :ALT) Right Now?

Plus, the 36-month beta value for ALT is at 1.65. Opinions of the stock are interesting as 7 analysts out of 7 who provided ratings for Altimmune Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!


The average price from analysts is $40.86. ALT currently public float of 36.01M and currently shorts hold a 14.61% ratio of that float. Today, the average trading volume of ALT was 1.11M shares.

ALT’s Market Performance

ALT stocks went up by 8.98% for the week, with a monthly jump of 5.55% and a quarterly performance of -16.59%, while its annual performance rate touched 132.73%. The volatility ratio for the week stands at 10.31% while the volatility levels for the past 30 days are set at 7.63% for Altimmune Inc.. The simple moving average for the period of the last 20 days is 6.00% for ALT stocks with a simple moving average of 1.81% for the last 200 days.

Analysts’ Opinion of ALT

Many brokerage firms have already submitted their reports for ALT stocks, with H.C. Wainwright repeating the rating for ALT by listing it as a “Buy.” The predicted price for ALT in the upcoming period, according to H.C. Wainwright is $35 based on the research report published on June 02nd of the current year 2021.

Guggenheim, on the other hand, stated in their research note that they expect to see ALT reach a price target of $36. The rating they have provided for ALT stocks is “Buy” according to the report published on February 11th, 2021.

Jefferies gave a rating of “Buy” to ALT, setting the target price at $25 in the report published on December 14th of the previous year.

ALT Trading at 6.30% from the 50-Day Moving Average

After a stumble in the market that brought ALT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.89% of loss for the given period.

Volatility was left at 7.63%, however, over the last 30 days, the volatility rate increased by 10.31%, as shares surge +9.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.91% upper at present.

During the last 5 trading sessions, ALT rose by +8.98%, which changed the moving average for the period of 200-days by -35.97% in comparison to the 20-day moving average, which settled at $13.34. In addition, Altimmune Inc. saw 24.82% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ALT starting from Hodges Philip, who sale 6,000 shares at the price of $16.08 back on Mar 01. After this action, Hodges Philip now owns 8,731 shares of Altimmune Inc., valued at $96,480 using the latest closing price.

Schafer Klaus, the Director of Altimmune Inc., purchase 2,000 shares at $11.99 during a trade that took place back on Dec 10, which means that Schafer Klaus is holding 8,900 shares at $23,980 based on the most recent closing price.

Stock Fundamentals for ALT

Current profitability levels for the company are sitting at:

  • -470.78 for the present operating margin

The net margin for Altimmune Inc. stands at -599.20. The total capital return value is set at -28.03, while invested capital returns managed to touch -35.75. Equity return is now at value -31.90, with -28.40 for asset returns.

Based on Altimmune Inc. (ALT), the company’s capital structure generated 0.81 points at debt to equity in total, while total debt to capital is 0.80. Total debt to assets is 0.74, with long-term debt to equity ratio resting at 0.65. Finally, the long-term debt to capital ratio is 0.64.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

When we switch over and look at the enterprise to sales, we see a ratio of 9.17, with the company’s debt to enterprise value settled at 0.02. The receivables turnover for the company is 1.17 and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 19.16.

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.